CardioSecur Aviation – Closing the Diagnostic Gap at 35,000 Feet
Actual or suspected heart attacks are among the most common reasons for costly flight diversions. With an aging global passenger demographic and the physiological strain of flying, in-flight cardiac emergencies are rising — and they will continue to do so. When a passenger shows cardiac symptoms mid-flight, the critical question is always the same: is this life-threatening, or can we safely continue? Without comprehensive ECG data on board, no physician — whether in the cabin or on the ground — can answer that question with confidence. Misled decisions put passengers at risk, disrupt flight schedules, trigger costly diversions, and expose airlines to reputational and legal consequences.
CardioSecur Aviation was built to solve exactly this problem. Our German-engineered, ultra-mobile 12+ lead ECG technology was developed in direct cooperation with airlines and their crews. The result is a device that is striking in its simplicity and technical sophistication — requiring virtually no training to operate. It integrates seamlessly with existing airline emergency workflows and ground-based medical support services. Over years of proven onboard operation, CardioSecur has officially demonstrated its ability to prevent unnecessary diversions while increasing passenger safety. From take-off to landing, we give cockpit and cabin crews the diagnostic clarity they need to make the right call.
Confidence — only a heartbeat away.
For more information, please visit: www.cardiosecur.com